))
Ozempic & Wegovy have arrived. Here's what it means for investors.
Manage episode 461185251 series 3467190
Contenido proporcionado por Adam Lang and Fear and Greed. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Adam Lang and Fear and Greed o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
GLP-1 drugs like Ozempic and Wegovy are some of the biggest developments in global health in years.
Steve Wheen, Managing Director, Equity Research at Jarden, talks to Sean Aylmer about the investment opportunities associated with these drugs, and the potential risk to other companies in the healthcare sector.
This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.
Support the show: http://fearandgreed.com.au
See omnystudio.com/listener for privacy information.
2215 episodios
Compartir
